Registry of Lobbyists

Monthly Communication Report

5031-311203

Corporation: PURDUE PHARMA
Associated registration: 872452-5031-12
Communication date: 2013-12-03
Posted date: 2014-01-15

Designated Public Office Holders who participated in the communication: Anne Lamar, Associate Assistant Deputy Minister
Health Products and Food Branch, Health Canada (HC)

Barbara Moran, Director, Prescription Drug Abuse Lead
CONTROLLED SUBSTANCES AND TOBACCO DIRECTORATE, Health Canada (HC)

Hilary Geller, Assistant Deputy Minister
Health Environments and Consumer Safety Branch, Health Canada (HC)

Barbara Sabourin, Director General
Therapeutic Products Directorate, Health Canada (HC)

Supriya Sharma, Senior Medical Advisor
Health Products and Food Branch, Health Canada (HC)
 
Subject Matter of the communication: Health
 
Responsible Officer who filed this communication report: Craig Landau
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: